Phase 3 registrational trial

1 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Radiopharm Theranostics Partners with Siemens on RAD101 PET Imaging Agent for Brain Metastases

Radiopharm Theranostics and Siemens Healthineers sign manufacturing supply agreement for RAD101 PET imaging agent, advancing toward Phase 3 trial with strong interim data.
SMMNYRADXradiopharmaceuticalsPET imaging